Brian Walters
Brian D. Walters serves as Executive Vice-President and General Counsel for Matthews International Corporation, Pittsburgh’s oldest company in continuous operation since 1850 and operating in over 25 countries with over 12,000 employees. During his 18-year tenure at Matthews, the Company has more than tripled in annual revenue, now producing approximately $1.8 billion in sales. Brian has directed all legal matters for this publicly-traded corporation both nationally and internationally, as well as serving as a member of Matthews’ executive leadership team. Mr. Walters has led over 75 domestic and foreign acquisition initiatives at Matthews, including extensive experience coordinating strategies to secure transaction approval from the U.S. Federal Trade Commission, managing HSR filings, as well as filings with the competition authority of the European Union.
Matthew Jones
Matthew has extensive experience of acting in large scale UK and multi-jurisdictional patent litigation. Matthew has acted in litigation relating to a wide range of technologies, including pharmaceuticals, biotechnology, optics, mechanical devices, electronics, telecommunications, and cryptography.
Before joining EIP, Matthew worked as Senior Counsel for Teva Pharmaceuticals Europe. During this time Matthew managed high-profile litigation in the UK, Germany, France, and the Netherlands, including Generics [UK] Ltd v Yeda & Teva, which related to the blockbuster drug Copaxone®.
Matthew has a degree in Biochemistry from Bristol University and a PhD in Biochemistry (specialising in quantum enzymology) from Leicester University.
